Comparison of Platinum-containing Doublet Chemotherapy and Liposome Paclitaxel Monotherapy for the Treatment of Elderly Patients with Advanced Non-small Cell Lung Cancer

Jemal A, Siegel R, Xu J, et al. Cancer statistics, 2010. CA Cancer J Clin,2010;60(5):277-300.

Spiro SG, Silvestri GA. The treatment of advanced non-small cell lung cancer. Curr Opin Pulm Med,2005;11(4):287-291.

Rossi A, Gridelli C. Chemotherapy of advanced non-small cell lung cancer in elderly patients. Ann Oncol,2006;17(Suppl 2):ii58-ii60.

Quoix E, Zalcman G, Oster JP, et al. Carboplatin and weekly paclitaxel doublet chemotherapy compared with monotherapy in elderly patients with advanced non-small-cell lung cancer:IFCT-0501 randomised, phase 3 trial. Lancet,2011;378(9796):1079-1088.

Zhi XY, Wu YL, Bu H, et al. Chinese guidelines on the diagnosis and treatment of primary lung cancer (2011). J Thorac Dis,2012;4(1):88-101.

Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst,2000;92(3):205-216.

Gridelli C, Maione P, Comunale D, et al. Adjuvant chemotherapy in elderly patients with non-small-cell lung cancer. Cancer control,2007;14(1):57-62.

Cappuzzo F, Bartolini S, Ceresoli GL, et al. Efficacy and tolerability of gefitinib in pretreated elderly patients with advanced non-small-cell lung cancer (NSCLC). Br J Cancer,2004;90(1):82-86.

The Elderly Lung Cancer Vinorelbine Italian Study Group. Effects of vinorelbine on quality of life and survival of elderly patients with advanced non-small-cell lung cancer. J Natl Cancer Insti,1999;91(1):66-72.

Gridelli C, Perrone F, Gallo C, et al. Chemotherapy for elderly patients with advanced non-small-cell lung cancer:The Multicenter Italian Lung Cancer in the Elderly Study (MILES) Phase Ⅲ Randomized Trial. J Natl Cancer Insti,2003;95(5):362-372.

Abe T, Yokoyama A, Takeda K, et al. Randomized phase Ⅲ trial comparing weekly docetaxel-cisplatin combination with triweekly docetaxel alone in elderly patients with advance non-small cell lung cancer:an intergroup tiral of JCOG0803/WJOG4307L (abstract #7509). J Clin Oncol,2011;29:478s.

Ramalingam SS, Khuri FR. The role of the taxanes in the treatment of older patients with advanced stage non-small cell lung cancer. Oncologist,2009;14(4):411-424.

Wang X, Zhou J, Wang Y, et al. A phase Ⅰ clinical and pharmacokinetic study of paclitaxel liposome infused in non-small cell lung cancer patients with malignant pleural effusions. Eur J Cancer,2010;46(8):1474-1480.